Management of Lobular Neoplasia Diagnosed by Core Biopsy

Lobular neoplasia (LN) involves proliferative changes within the breast lobules. LN is divided into lobular carcinoma in situ (LCIS) and atypical lobular hyperplasia (ALH). LCIS can be further subdivided into three subtypes: classic LCIS, pleomorphic LCIS, and LCIS with necrosis (florid type). Becau...

Full description

Saved in:
Bibliographic Details
Main Authors: Chinmay Jani, Margaret Lotz, Sarah Keates, Yasha Gupta, Alexander Walker, Omar Al Omari, Arshi Parvez, Dipesh Patel, Maria Gnata, John Perry, Leila Khorashadi, Lisa Weissmann, Susan E. Pories
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:The Breast Journal
Online Access:http://dx.doi.org/10.1155/2023/8185446
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832559698899894272
author Chinmay Jani
Margaret Lotz
Sarah Keates
Yasha Gupta
Alexander Walker
Omar Al Omari
Arshi Parvez
Dipesh Patel
Maria Gnata
John Perry
Leila Khorashadi
Lisa Weissmann
Susan E. Pories
author_facet Chinmay Jani
Margaret Lotz
Sarah Keates
Yasha Gupta
Alexander Walker
Omar Al Omari
Arshi Parvez
Dipesh Patel
Maria Gnata
John Perry
Leila Khorashadi
Lisa Weissmann
Susan E. Pories
author_sort Chinmay Jani
collection DOAJ
description Lobular neoplasia (LN) involves proliferative changes within the breast lobules. LN is divided into lobular carcinoma in situ (LCIS) and atypical lobular hyperplasia (ALH). LCIS can be further subdivided into three subtypes: classic LCIS, pleomorphic LCIS, and LCIS with necrosis (florid type). Because classic LCIS is now considered as a benign etiology, current guidelines recommend close follow-up with imaging versus surgical excision. The goal of our study was to determine if the diagnosis of classic LN on core needle biopsy (CNB) merits surgical excision. This is a retrospective, observational study conducted at Mount Auburn Hospital, Cambridge, MA, from May 17, 2017, through June 30, 2020. We reviewed the data of breast biopsies conducted at our hospital over this period and included patients who were diagnosed with classic LN (LCIS and/or ALH) and excluded patients having any other atypical lesions on CNB. All known cancer patients were excluded. Of the 2707 CNBs performed during the study period, we identified 68 women who were diagnosed with ALH or LCIS on CNB. CNB was performed for an abnormal mammogram in the majority of patients (60; 88%) while 7(10.3%) had an abnormal breast magnetic resonance imaging study (MRI), and 1 had an abnormal ultrasound (US). A total of 58 patients (85%) underwent excisional biopsy, of which 3 (5.2%) showed malignancy, including 2 cases of DCIS and 1 invasive carcinoma. In addition, there was 1 case (1.7%) with pleomorphic LCIS and 11 cases with ADH (15.5%). The management of LN found on core biopsy is evolving, with some advocating surgical excision and others recommending observation. Our data show a change in diagnosis with excisional biopsy in 13 (22.4%) of patients with 2 cases of DCIS, 1 invasive carcinoma, 1 pleomorphic LCIS, and 9 cases of ADH, diagnosed on excisional biopsy. While ALH and classic LCIS are considered benign, the choice of ongoing surveillance versus excisional biopsy should be made with shared decision making with the patient, with consideration of personal and family history, as well as patient preferences.
format Article
id doaj-art-713800bea15049509e325a385f518b05
institution Kabale University
issn 1524-4741
language English
publishDate 2023-01-01
publisher Wiley
record_format Article
series The Breast Journal
spelling doaj-art-713800bea15049509e325a385f518b052025-02-03T01:29:27ZengWileyThe Breast Journal1524-47412023-01-01202310.1155/2023/8185446Management of Lobular Neoplasia Diagnosed by Core BiopsyChinmay Jani0Margaret Lotz1Sarah Keates2Yasha Gupta3Alexander Walker4Omar Al Omari5Arshi Parvez6Dipesh Patel7Maria Gnata8John Perry9Leila Khorashadi10Lisa Weissmann11Susan E. Pories12Department of Internal MedicineHarvard Medical SchoolHarvard Medical SchoolHarvard Medical SchoolDepartment of Internal MedicineDepartment of Internal MedicineDepartment of Internal MedicineHarvard Medical SchoolHoffman Breast CenterDepartment of PathologyHarvard Medical SchoolDepartment of Internal MedicineHarvard Medical SchoolLobular neoplasia (LN) involves proliferative changes within the breast lobules. LN is divided into lobular carcinoma in situ (LCIS) and atypical lobular hyperplasia (ALH). LCIS can be further subdivided into three subtypes: classic LCIS, pleomorphic LCIS, and LCIS with necrosis (florid type). Because classic LCIS is now considered as a benign etiology, current guidelines recommend close follow-up with imaging versus surgical excision. The goal of our study was to determine if the diagnosis of classic LN on core needle biopsy (CNB) merits surgical excision. This is a retrospective, observational study conducted at Mount Auburn Hospital, Cambridge, MA, from May 17, 2017, through June 30, 2020. We reviewed the data of breast biopsies conducted at our hospital over this period and included patients who were diagnosed with classic LN (LCIS and/or ALH) and excluded patients having any other atypical lesions on CNB. All known cancer patients were excluded. Of the 2707 CNBs performed during the study period, we identified 68 women who were diagnosed with ALH or LCIS on CNB. CNB was performed for an abnormal mammogram in the majority of patients (60; 88%) while 7(10.3%) had an abnormal breast magnetic resonance imaging study (MRI), and 1 had an abnormal ultrasound (US). A total of 58 patients (85%) underwent excisional biopsy, of which 3 (5.2%) showed malignancy, including 2 cases of DCIS and 1 invasive carcinoma. In addition, there was 1 case (1.7%) with pleomorphic LCIS and 11 cases with ADH (15.5%). The management of LN found on core biopsy is evolving, with some advocating surgical excision and others recommending observation. Our data show a change in diagnosis with excisional biopsy in 13 (22.4%) of patients with 2 cases of DCIS, 1 invasive carcinoma, 1 pleomorphic LCIS, and 9 cases of ADH, diagnosed on excisional biopsy. While ALH and classic LCIS are considered benign, the choice of ongoing surveillance versus excisional biopsy should be made with shared decision making with the patient, with consideration of personal and family history, as well as patient preferences.http://dx.doi.org/10.1155/2023/8185446
spellingShingle Chinmay Jani
Margaret Lotz
Sarah Keates
Yasha Gupta
Alexander Walker
Omar Al Omari
Arshi Parvez
Dipesh Patel
Maria Gnata
John Perry
Leila Khorashadi
Lisa Weissmann
Susan E. Pories
Management of Lobular Neoplasia Diagnosed by Core Biopsy
The Breast Journal
title Management of Lobular Neoplasia Diagnosed by Core Biopsy
title_full Management of Lobular Neoplasia Diagnosed by Core Biopsy
title_fullStr Management of Lobular Neoplasia Diagnosed by Core Biopsy
title_full_unstemmed Management of Lobular Neoplasia Diagnosed by Core Biopsy
title_short Management of Lobular Neoplasia Diagnosed by Core Biopsy
title_sort management of lobular neoplasia diagnosed by core biopsy
url http://dx.doi.org/10.1155/2023/8185446
work_keys_str_mv AT chinmayjani managementoflobularneoplasiadiagnosedbycorebiopsy
AT margaretlotz managementoflobularneoplasiadiagnosedbycorebiopsy
AT sarahkeates managementoflobularneoplasiadiagnosedbycorebiopsy
AT yashagupta managementoflobularneoplasiadiagnosedbycorebiopsy
AT alexanderwalker managementoflobularneoplasiadiagnosedbycorebiopsy
AT omaralomari managementoflobularneoplasiadiagnosedbycorebiopsy
AT arshiparvez managementoflobularneoplasiadiagnosedbycorebiopsy
AT dipeshpatel managementoflobularneoplasiadiagnosedbycorebiopsy
AT mariagnata managementoflobularneoplasiadiagnosedbycorebiopsy
AT johnperry managementoflobularneoplasiadiagnosedbycorebiopsy
AT leilakhorashadi managementoflobularneoplasiadiagnosedbycorebiopsy
AT lisaweissmann managementoflobularneoplasiadiagnosedbycorebiopsy
AT susanepories managementoflobularneoplasiadiagnosedbycorebiopsy